Role of drug transporters and drug accumulation in the temporal acquisition of drug resistance

Role of drug transporters and drug accumulation in the temporal acquisition of drug resistance

<p>Abstract</p> <p>Background</p> <p>Anthracyclines and taxanes are commonly used in the treatment of breast cancer. However, tumor resistance to these drugs often develops, possibly due to overexpression of drug transporters. It remains unclear whether drug resistance...

Full description

Bibliographic Details
Main Authors:	Veitch Zachary, Guo Baoqing, Villeneuve David J, Laberge Monique L, Hembruff Stacey L, Cecchetto Melanie, Parissenti Amadeo M
Format:	Article
Language:	English
Published:	BMC 2008-11-01
Series:	BMC Cancer
Online Access:	http://www.biomedcentral.com/1471-2407/8/318

Similar Items

Alterations in estrogen signalling pathways upon acquisition of anthracycline resistance in breast tumor cells.
by: Simon Chewchuk, et al.
Published: (2017-01-01)

Inflammatory cytokine production in tumor cells upon chemotherapy drug exposure or upon selection for drug resistance.
by: Derek W Edwardson, et al.
Published: (2017-01-01)

Deception and Drug Acquisition
by: Amber N. Sanders, et al.
Published: (2016-07-01)

Renal drug transporters and their significance in drug–drug interactions
by: Jia Yin, et al.
Published: (2016-09-01)

Enantioselective Drug Recognition by Drug Transporters
by: Yuichi Uwai
Published: (2018-11-01)

Transporter-Mediated Drug–Drug Interactions with Oral Antidiabetic Drugs
by: Jörg König, et al.
Published: (2011-10-01)

Drug transport and drug-drug interactions at the blood-brain barrier
by: Raedisch, Steffen
Published: (2014)

Drug transport kinetics of intravascular triggered drug delivery systems
by: Timo L. M. ten Hagen, et al.
Published: (2021-07-01)

Role of Drug Metabolic Enzymes and Transporters in Drug-Drug Interactions Between Antiretroviral and Antituberculosis Drugs
by: Md Masud Parvez, et al.
Published: (2018-04-01)

Metabolism, Transport and Drug–Drug Interactions of Silymarin
by: Ying Xie, et al.
Published: (2019-10-01)

Drug Transport in Cell Preparations with Diffusional Dosing and Temporal Ratiometry
by: Oruganti, Prasad
Published: (2010)

Islatravir Is Not Expected to Be a Victim or Perpetrator of Drug-Drug Interactions via Major Drug-Metabolizing Enzymes or Transporters
by: Kelly Bleasby, et al.
Published: (2021-08-01)

Drug ingredient acquisition cost determination for third-party prescription drug programs /
by: Wadelin, Jeffrey W.
Published: (1986)

Acquisition of drug resistance and dependence by prions.
by: Anja M Oelschlegel, et al.
Published: (2013-02-01)

Drug transporters in the nasal epithelia and their contribution in drug delivery
by: Al-Ghabeish, Manar I.
Published: (2014)

Drug-Drug Interactions at Organic Cation Transporter 1
by: Shiwei Zhou, et al.
Published: (2021-02-01)

Drug Interactions of Metformin Involving Drug Transporter Proteins
by: Naina Mohamed Pakkir Maideen, et al.
Published: (2017-12-01)

The Temporal Hormesis of Drug Therapies
by: Noor Dudekula, et al.
Published: (2005-07-01)

Induction of Multiple Drug Transporters by Efavirenz
by: Johanna Weiss, et al.
Published: (2009-01-01)

Liposomes and drug transport
by: Tuzel, Sadiye Nilden
Published: (1983)

Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets
by: Marçal ePastor-Anglada, et al.
Published: (2015-02-01)

In vitro and in silico prediction of drug-drug interactions with transport proteins
by: Ahlin, Gustav
Published: (2009)

Self Regulatory Drug Transport: An Intelligent Drug Delivery System
by: Ashish Jain, et al.

In vitro and in silico Predictions of Hepatic Transporter-Mediated Drug Clearance and Drug-Drug Interactions in vivo
by: Vildhede, Anna
Published: (2015)

Investigations on mechanisms of acquisition of drug resistance in trypanosomes
by: Suswam, Esther Azungwe
Published: (1998)

Drug Metabolizing Enzyme, Drug Transporter Expression And Drug Disposition Are Altered In Models Of Inflammatory Liver Disease
by: Lickteig, Andrew Joseph
Published: (2007)

Nanoparticles of cisplatin augment drug accumulations and inhibit multidrug resistance transporters in human glioblastoma cells
by: Naseer Maliyakkal, et al.
Published: (2021-08-01)

In silico Prioritization of Transporter–Drug Relationships From Drug Sensitivity Screens
by: Adrián César-Razquin, et al.
Published: (2018-09-01)

Role of drug transporters in drug development: a qualitative and quantitative approach
by: Sumit Basu, et al.
Published: (2017-06-01)

Endogenous Biomarkers for SLC Transporter-Mediated Drug-Drug Interaction Evaluation
by: Yang Li, et al.
Published: (2021-09-01)

Facilitating the Cellular Accumulation of Pt-Based Chemotherapeutic Drugs
by: Ian Henry Lambert, et al.
Published: (2018-08-01)

The role of transporters on drug therapy
by: . Ngatidjan
Published: (2016-02-01)

Modulation of Urate Transport by Drugs
by: Péter Tátrai, et al.
Published: (2021-06-01)

Drug Metabolism/Transport and Pharmacokinetics
Published: (2021)

Drug and non-drug treatments of vertigo
by: L. M. Antonenko
Published: (2021-03-01)

THE SLC22 TRANSPORTER FAMILY: NOVEL INSIGHTS TO ROLES IN DRUG EFFICACY, DRUG-DRUG INTERACTIONS AND MOOD DISORDERS
by: Pan, Xiaolei
Published: (2015)

P-glycoprotein- and organic anion-transporting polypeptide-mediated transport of periplocin may lead to drug–herb/drug–drug interactions
by: Liang S, et al.
Published: (2014-05-01)

Transdermal microconduits by microscission for drug delivery and sample acquisition
by: Anderson R, et al.
Published: (2004-04-01)

Transdermal microconduits by microscission for drug delivery and sample acquisition
by: Gonzalez, Salvador, et al.
Published: (2010)

Optimization of Drug Delivery by Drug-Eluting Stents.
by: Franz Bozsak, et al.
Published: (2015-01-01)